ltrafiltration effect on coronary artery bypass surgery

Phase 2

Conditions: Coronary Artery Disease.
Atherosclerotic cardiovascular disease, so described

Registration Number: IRCT2016092229914N1

Lead Sponsor: Vice CHancellor For Research, Iran university Of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 75

Inclusion Criteria

Non-inclusion criteria
Liver failure as ((AST> 40 unit / L) and (ALT> 40 unit / L);A history of heart surgery;High serum creatinine1/5mg / dL; And patients who received the drug because before during 5 days acute renal failure have had severe narrowing of the carotid both carotid or one of them; Surgery emergency; IE; Ejection fraction of the left ventricle less than 30 percent of patients with Severe failure right ventricle Hemoglobin less than 10;Mass index BMI greater than 40;Benign and malignant cancers;Clamped aortic bypass for more than 120 minutes and 150 minutes; Pulmonary function test abnormal preoperative FEV1 <65

Exclusion criteria
Prime 8/5000
Autologus do the opposite; Using the CUF; Using MUF; Patient died during surgery; Use of Intraoperative balloon pump;Use of ECMO; The need to stay open sternum after surgery; The patient needs cardiopulmonary resuscitation

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cerebral oxygenation. Timepoint: 1.Preoperative2.Start operation3.Intraoperative4.Postoperative2. Method of measurement: Invos devices.;Arterial blood gases. Timepoint: Before surgery2.Start operation3.Intraoperative4.End the practice of5.6 hours after surgery. Method of measurement: Arterial blood gas measurement.;Liver enzymes. Timepoint: Preoperative and postoperative. Method of measurement: Measured by laboratory.;Kidney enzymes. Timepoint: Preoperative and postoperative. Method of measurement: Measured by laboratory.;Cardiac arrhythmia. Timepoint: Preoperative and postoperative. Method of measurement: ECG machine.

Secondary Outcome Measures